ABBVABBVIE INC.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 11177
Ticker: ABBV
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2012-12-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ABBV

Detail

Enriched 2026-08-14 20:47

Market cap: $439,588,095,816.6
Shares outstanding (class): 1,766,792,821
Shares outstanding (weighted): 1,767,117,285
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 57,000
Location: NORTH CHICAGO, IL
Homepage: https://www.abbvie.com
Description: AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Market cap and share counts drift.

Funds holding this security

712 funds · 755 positions · $68.08B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$12.21B	0.61%	56,153,718 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$9.77B	0.69%	44,913,066 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$4.94B	0.69%	22,731,241 NS	FIGI
N/A —	—	$4.48B	0.69%	20,585,575 NS	FIGI
VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS	VTV	$3.56B	1.58%	16,354,949 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$2.80B	7.25%	12,861,501 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$2.17B	0.69%	9,965,284 NS	FIGI
Investment Co of America Investment Co of America	—	$1.81B	1.09%	8,308,752 NS	FIGI
iShares Russell 1000 Growth ETF iShares Trust	IWF	$1.55B	1.39%	7,143,618 NS	FIGI
American Balanced Fund American Balanced Fund	—	$854.60M	0.32%	3,929,387 NS	FIGI
JPMorgan Large Cap Growth Fund JPMorgan Trust II	—	$816.71M	0.76%	3,755,170 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST	SPYM	$808.06M	0.69%	3,715,386 NS	FIGI
JPMorgan Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust	JEPI	$685.47M	1.56%	3,151,752 NS	FIGI
Franklin Income Fund Franklin Custodian Funds	—	$652.47M	0.83%	3,000,000 NS	FIGI
JPMorgan U.S. Equity Fund JPMorgan Trust I	—	$531.28M	1.68%	2,442,778 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERABBV
FIGI_COMPOSITEBBG0025Y4RY4
FIGI_SHARE_CLASSBBG0025Y4RZ3
CIK0001551152
ISINUS00287Y1091
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 1
Model: deepseek
Rationale: AbbVie is a pharmaceutical company, classified under healthcare and pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.